The Vanguard Group, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:The Vanguard Group, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15352
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

The Vanguard Group, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

The Vanguard Group, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Vanguard Group, Inc. (Vanguard or “the company”) is the US based investment management company. The company provides investment products such as Vanguard mutual funds, Vanguard exchange-traded funds (ETFs), other mutual funds, stocks and other ETFs, CDs and bonds. Besides that, it offers services such as include retirement plan participants, institutional investors, financial professionals, and non-US investors. It also offers mutual funds, stocks, exchange traded funds, bonds, annuities, certificates of deposits, estate planning, retirement income, personal services, account services, and guidance to personal investors. The company provides its products and services across the Americas, Europe and Asia Pacific. The company is headquartered in Valley Forge, Pennsylvania, the US.

Scope

- Detailed information on The Vanguard Group, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Vanguard Group, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of The Vanguard Group, Inc. including a breakdown and examination of key business segments
- Intelligence on The Vanguard Group, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Vanguard Group, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Vanguard Group, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Vanguard Group, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Vanguard Group, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
The Vanguard Group, Inc.: Company Overview
The Vanguard Group, Inc.: Overview and Key Facts
The Vanguard Group, Inc.: Overview
The Vanguard Group, Inc.: Key Facts
The Vanguard Group, Inc.: Key Employees
The Vanguard Group, Inc.: Key Employee Biographies
The Vanguard Group, Inc.: Major Products and Services
The Vanguard Group, Inc.: Company History
The Vanguard Group, Inc.: Locations and Subsidiaries
The Vanguard Group, Inc.: Key Competitors
The Vanguard Group, Inc.: Company Analysis
The Vanguard Group, Inc.: Business Description
The Vanguard Group, Inc.: SWOT Analysis
The Vanguard Group, Inc.: SWOT Overview
The Vanguard Group, Inc.: Strengths
The Vanguard Group, Inc.: Weaknesses
The Vanguard Group, Inc.: Opportunities
The Vanguard Group, Inc.: Threats
The Vanguard Group, Inc.: Corporate Financial Deals Activity
The Vanguard Group, Inc.: Financial Deals Overview
The Vanguard Group, Inc.: Targets and Partners
The Vanguard Group, Inc.: Top Deals 2015 – 2019YTD*
The Vanguard Group, Inc.: Corporate Venturing
The Vanguard Group, Inc.: Divestments
The Vanguard Group, Inc.: Recent Developments
The Vanguard Group, Inc.: News and Events Summary
The Vanguard Group, Inc.: Business Expansion
The Vanguard Group, Inc.: Corporate Governance
The Vanguard Group, Inc.: Financial Deals
The Vanguard Group, Inc.: Research & Development
The Vanguard Group, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: The Vanguard Group, Inc.: Key Facts
Table 2: The Vanguard Group, Inc.: Key Employees
Table 3: The Vanguard Group, Inc.: Company History
Table 4: The Vanguard Group, Inc.: Locations and Subsidiaries
Table 5: The Vanguard Group, Inc.: Key Competitors
Table 6: The Vanguard Group, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: The Vanguard Group, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: The Vanguard Group, Inc.: Targets and Partners
Table 9: The Vanguard Group, Inc.: Top Deals 2015 - 2019YTD*
Table 10: The Vanguard Group, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 11: The Vanguard Group, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 12: The Vanguard Group, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 13: The Vanguard Group, Inc.: Divestments by Geography (2015 - YTD*2019)
Table 14: The Vanguard Group, Inc.: News and Events Summary
Table 15: The Vanguard Group, Inc.: Business Expansion
Table 16: The Vanguard Group, Inc.: Corporate Governance
Table 17: The Vanguard Group, Inc.: Financial Deals
Table 18: The Vanguard Group, Inc.: Research & Development
Table 19: The Vanguard Group, Inc.: Strategy and Operations

List of Figures
Figure 1: The Vanguard Group, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Vanguard Group, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: The Vanguard Group, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 4: The Vanguard Group, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 5: The Vanguard Group, Inc.: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 6: The Vanguard Group, Inc.: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[The Vanguard Group, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Caltex Australia Ltd (CTX):企業の財務・戦略的SWOT分析
    Caltex Australia Ltd (CTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Monsanto Company:企業の戦略・SWOT・財務分析
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mapfre S.A. (MAP):企業の財務・戦略的SWOT分析
    Mapfre S.A. (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Centauri Therapeutics Ltd (Centauri Therapeutics) is a biotechnology company that discovers and develops novel molecules for life threatening diseases. The company uses alphamer technology to develop anti-infective therapeutics. Its alphamer technology is based on programmable immunity in wh …
  • Connect Catering Limited:企業の戦略・SWOT・財務情報
    Connect Catering Limited - Strategy, SWOT and Corporate Finance Report Summary Connect Catering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Champion Aerospace LLC:企業の戦略・SWOT・財務情報
    Champion Aerospace LLC - Strategy, SWOT and Corporate Finance Report Summary Champion Aerospace LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PayPoint plc:企業の戦略・SWOT・財務分析
    PayPoint plc - Strategy, SWOT and Corporate Finance Report Summary PayPoint plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Spectris Plc (SXS):企業の財務・戦略的SWOT分析
    Spectris Plc (SXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Narodowy Bank Polski:企業の戦略的SWOT分析
    Narodowy Bank Polski - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Genexine Inc (095700):製薬・医療:M&Aディール及び事業提携情報
    Summary Genexine Inc (Genexine), formerly Genexine Co Ltd is a clinical stage biotechnology company that develops and commercialize immunotherapeutics and next generation novel long-acting biologics. The company develops therapeutic vaccines for incurable diseases and next-generation antibody fusion …
  • Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. It offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non-emergency …
  • Infinera Corp:企業の戦略・SWOT・財務分析
    Infinera Corp - Strategy, SWOT and Corporate Finance Report Summary Infinera Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • JXTG Holdings, Inc.:企業の戦略・SWOT・財務分析
    JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JXTG Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆